ADD CONDITION

items per page

Zeropain 5

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 5 mg/100 mL
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2023
Label revision date
May 31, 2023
Active ingredient
Lidocaine Hydrochloride 5 mg/100 mL
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2023
Label revision date
May 31, 2023
Manufacturer
Blackbull Store LLC
Registration number
M015
NDC root
83371-111

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Anesthetic anorectal cream is a topical medication designed to provide temporary relief from pain and itching associated with anorectal disorders. This cream can be particularly helpful if you are experiencing discomfort in that area, offering soothing effects to ease your symptoms.

While the specific mechanism of action is not detailed, the cream is formulated to target the discomfort directly at the site of application, helping you feel more comfortable during your recovery.

Uses

Anesthetic anorectal cream is designed to provide temporary relief from pain and itching associated with anorectal disorders. If you're experiencing discomfort in this area, this cream can help soothe your symptoms and make you feel more comfortable.

It's important to note that there are no reported teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects associated with this cream. This makes it a safer option for those in need of relief from anorectal discomfort.

Dosage and Administration

To use this medication effectively, start by cleaning the affected area thoroughly. For adults and children aged 2 years and older, you should apply the medication to the affected area no more than 3 to 4 times a day. If you prefer, you can remove any residue after application.

If your child is under 2 years old, it’s important to consult a doctor before using this medication. This ensures that you receive the best advice tailored to your child's needs.

What to Avoid

It's important to be mindful of when to stop using this product. If your condition worsens, symptoms persist for more than seven days, or if they clear up and then return within a few days, you should stop using it and consult a doctor. Additionally, if you experience any rash or irritation that develops, persists, or worsens, seek medical advice.

If you are pregnant or breastfeeding, please consult a healthcare professional before using this product to ensure it is safe for you and your baby.

Side Effects

When using this product, it's important to be aware of potential side effects. You should stop using it and consult a doctor if your condition worsens, if symptoms last more than seven days, or if they clear up and then return within a few days. Additionally, if you notice any rash or irritation that develops, persists, or worsens, seek medical advice.

This product is for external use only, so avoid contact with your eyes and do not use it for prolonged periods or in large amounts, especially on raw or blistered skin. If you are pregnant or breastfeeding, it's advisable to consult a healthcare professional before using this product.

Warnings and Precautions

This product is intended for external use only, so please avoid contact with your eyes. It’s important not to use it for a long time or in large amounts, especially on raw or blistered skin. Keep it out of reach of children, and if it is swallowed, seek medical help immediately or contact a Poison Control Center at +1 800-222-1222.

You should stop using this product and consult your doctor if your condition worsens, if symptoms last more than seven days, or if they clear up and then return within a few days. Additionally, if you develop a rash or irritation that persists or worsens, or if you are pregnant or breastfeeding, please talk to a healthcare professional before continuing use.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to err on the side of caution when it comes to your health. Remember, if you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If your child is under 2 years old, it's important to consult a doctor before using this medication. For children aged 2 years and older, you can apply the medication to the affected area, but make sure to clean the area first. You should only apply it 3 to 4 times a day to ensure safe and effective use. Always follow these guidelines to help keep your child safe and healthy.

Geriatric Use

While there is no specific information about the use of ZEROPAIN 5 topical anesthetic cream in older adults, it's important to approach its use with caution. Since the drug insert does not mention any dosage adjustments or safety concerns for elderly patients, you should consult with a healthcare professional before using this cream. They can provide personalized advice based on your health status and any other medications you may be taking. Always prioritize safety and ensure that any treatment is appropriate for your individual needs.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for your specific situation. They can help determine the best approach based on your liver function and overall health.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no specific drug interactions or laboratory test interactions noted for your treatment. This ensures that your healthcare team can monitor your health effectively and make informed decisions about your care.

Always feel free to ask questions and share all the medications and supplements you are using. This way, you can work together to ensure your treatment is safe and effective.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dry place at a temperature between 15 to 30°C (59 to 86°F). This temperature range helps maintain the product's effectiveness.

When handling the product, be sure to check the seal on the tube. If the seal is punctured or missing, do not use the product, as this indicates it may have been tampered with and could be unsafe. Always prioritize safety by following these guidelines closely.

Additional Information

You should apply this medication topically to the affected area, and it can be used by adults and children aged 2 years and older. Make sure to apply it no more than 3 to 4 times a day for best results. There are no additional details available regarding laboratory tests, abuse potential, or patient counseling.

FAQ

What is Anesthetic anorectal Cream used for?

Anesthetic anorectal Cream is used for the temporary relief of pain and itching due to anorectal disorders.

How should I use Anesthetic anorectal Cream?

For adults and children 2 years old and older, clean the affected area and apply the cream not more than 3 to 4 times daily.

What should I do if my symptoms persist?

Stop use and ask a doctor if your condition worsens, symptoms persist for more than seven days, or if rash or irritation develops.

Is Anesthetic anorectal Cream safe to use during pregnancy or breastfeeding?

If you are pregnant or breastfeeding, you should ask a health professional before using Anesthetic anorectal Cream.

Are there any contraindications for using this cream?

No contraindications are listed for Anesthetic anorectal Cream.

What precautions should I take when using this cream?

This cream is for external use only, avoid contact with eyes, and do not use in large quantities over raw surfaces or blistered areas.

What should I do if I accidentally swallow the cream?

Keep out of reach of children, and if swallowed, get medical help or contact a Poison Control Center immediately.

What is the storage condition for Anesthetic anorectal Cream?

Store the cream at 15 to 30°C (59 to 86°F).

Can children under 2 years old use this cream?

Consult a doctor before using Anesthetic anorectal Cream on children under 2 years old.

Packaging Info

Below are the non-prescription pack sizes of Zeropain 5 (topical anesthetic cream). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Zeropain 5.
Details

Drug Information (PDF)

This file contains official product information for Zeropain 5, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

This product is a cream formulation, packaged in a 2-ounce container. The National Drug Code (NDC) for this product is 83371-111-11.

Uses and Indications

Anesthetic anorectal cream is indicated for the temporary relief of pain and itching associated with anorectal disorders.

There are no teratogenic or nonteratogenic effects associated with the use of this cream.

Dosage and Administration

For adults and children aged 2 years and older, the affected area should be cleaned prior to application. The product may be applied to the affected area no more than 3 to 4 times daily. If desired, any residue can be removed after application.

For children under 2 years of age, it is recommended to consult a healthcare professional before use.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional under the following circumstances:

  • If the condition worsens.

  • If symptoms persist for more than seven days or resolve and then recur within a few days.

  • If a rash or irritation develops, persists, or worsens.

  • If the individual is pregnant or breastfeeding, consultation with a healthcare professional is recommended prior to use.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes to prevent irritation or injury. Prolonged use of this product is not recommended, and it should not be applied in large quantities, especially over raw surfaces or blistered areas, as this may exacerbate adverse effects.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted at +1 800-222-1222.

Healthcare professionals should advise patients to discontinue use and consult a doctor if the condition worsens, if symptoms persist for more than seven days, or if symptoms clear up and then recur within a few days. Additionally, if a rash or irritation develops, persists, or increases, medical advice should be sought. Pregnant or breastfeeding individuals are encouraged to consult a health professional prior to use to ensure safety for both mother and child.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes. Prolonged use is not recommended, and it should not be applied in large quantities, especially over raw surfaces or blistered areas.

In clinical practice, patients are advised to stop use and consult a healthcare professional if the condition worsens, if symptoms persist for more than seven days, or if symptoms clear up and then recur within a few days. Additionally, if a rash or irritation develops, persists, or increases, medical advice should be sought.

For pregnant or breastfeeding individuals, it is important to consult a health professional before using this product to ensure safety for both the patient and the child.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Zeropain 5 (topical anesthetic cream). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Zeropain 5.
Details

Pediatric Use

Pediatric patients under 2 years old should consult a healthcare professional before use. For children aged 2 years and older, the affected area should be cleaned prior to application, which may be done no more than 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific dosage adjustments, safety concerns, or special precautions outlined in the prescribing information for ZEROPAIN 5 topical anesthetic cream. As such, healthcare providers should exercise caution when prescribing this medication to geriatric patients, given the absence of targeted clinical findings or recommendations for this population.

It is advisable for healthcare providers to monitor elderly patients closely for any potential adverse effects or unusual responses to treatment, considering the general physiological changes associated with aging that may affect drug metabolism and efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and breastfeeding safety. Healthcare providers can offer guidance tailored to individual circumstances, ensuring informed decision-making for both maternal and fetal health.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the medication is swallowed, they should seek medical help immediately or contact a Poison Control Center at +1 800-222-1222.

Patients should be informed to stop using the medication and consult a doctor if their condition worsens, if symptoms persist for more than seven days, or if symptoms clear up and then recur within a few days. Additionally, patients should be made aware that if they develop a rash or irritation that persists or increases, they should seek medical advice.

For patients who are pregnant or breastfeeding, it is essential to recommend that they consult a healthcare professional before using the medication.

Storage and Handling

The product is supplied in a tamper-evident tube. It is essential to inspect the seal prior to use; the product should not be utilized if the seal on the tube is punctured or missing.

For optimal storage, the product must be maintained at a temperature range of 15 to 30°C (59 to 86°F). Proper adherence to these storage conditions is crucial to ensure the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of no more than 3 to 4 times daily for adults and children aged 2 years and older. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Zeropain 5, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Zeropain 5, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.